Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia

Few reports assess prognosis during follow-up of patients with symptomatic Waldenström macroglobulinemia (WM). In 121 WM patients treated between 1993 and 2016, we analyzed the prognostic role during the clinical course of the initial International Prognostic Scoring System for WM (IPSSWM). Then, we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Guidez, Stephanie, Labreuche, Julien, Drumez, Elodie, Ysebaert, Loic, Bakala, Jana, Delette, Caroline, Hivert, Bénédicte, Protin, Caroline, Declercq, Hervé, Verlay, Mélanie, Marolleau, Jean Pierre, Duhamel, Alain, Morel, Pierre
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258926/
https://ncbi.nlm.nih.gov/pubmed/30455359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018021287
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados